semaglutide for psoriasis Effects of Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial semaglutide and psoriasis Psoriasis, RA

In the GLP-1 vs DPP-4 inhibitor cohort (2009-2022), we identified 108,322 new users of GLP-1 RAs and 55,411 new users of DPP-4 inhibitors using the National Prescription Registry

But the fundamentals dont change:No drug replaces discipline

1,3,43,44 Glomerulopathy is the primary pathologic finding of obesity-related kidney disease

Any patient with a hereditary variant is screened for other associated endocrine tumors, particularly parathyroid hyperplasia and pheochromocytoma

Stop at Satisfied, Not Full Learn the difference between "I could eat more" and "I'm satisfied." On GLP-1s, the jump from satisfied to uncomfortably full happens very quickly with just a few more bites